INDICATIONS

• Active Immunization: Vaccination of healthy dogs and puppies against disease caused by canine parvovirus.
• Early Age Protection: Field studies have shown the vaccine is safe and effective in puppies as young as 3 weeks of age.
• Maternal Antibody Override: Designed to provide immunity even in the presence of high-titer maternal antibodies that might neutralize weaker vaccines.
• Rapid Immunity: Stimulates antibody production (IgM and IgG) after the first dose, providing rapid protection, often within one dose, against all known strains.
• Booster Use: Used as a booster in adult dogs to maintain immunity. 

ADMINISTRATION

• Method: Subcutaneous (preferred) or intramuscular injection.
• Dose: 1 mL per dog.
• Preparation: Shake well before using; use new, sterile needles/syringes.
• Location: Inject beneath the loose skin over the shoulder, checking that the needle is not in a blood vessel.
• Schedule: Initial dose around 42 days old, followed by boosters every 14–21 days until 18 weeks old to overcome maternal antibodies.
• Adults: Dogs over 18 weeks should receive a single 1mL dose.
• Restrictions: Do not use on pregnant dogs.